[{"uuid": "45bccb20-268d-3075-a01b-a9521d2dfc3a", "title": "BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bmy-gets-positive-chmp-opinion-183400618.html", "providerPublishTime": 1738607640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SlGE5JR4xp73Vb5zTu29cQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iAjYTqhtpV3hPzryhmSe_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "9e6e3948-ae27-3ca0-9812-8bb103fbf920", "title": "Bet on These 4 Top-Performing Liquid Stocks for Solid Gains", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bet-4-top-performing-liquid-124000775.html", "providerPublishTime": 1738586400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vABZeSgWA8dsasAI3N0xLg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALNY", "FTDR", "EVER"]}, {"uuid": "7ae6ed39-40ab-38b2-9472-fbd0145412e6", "title": "Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/non-covid-drugs-drive-pfes-155300754.html", "providerPublishTime": 1738597980, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/o6eSXhh4drUv4ud46ya1fg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE", "ALNY", "BMRN"]}, {"uuid": "03730b0f-1b37-3159-ad6b-ad4a125314c8", "title": "Novartis Posts Q4 Earnings and Sales Beat, Shares Gain", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/novartis-posts-q4-earnings-sales-182000131.html", "providerPublishTime": 1738347600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yDFbSqgx8Di1WnwdhMZtig--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVS"]}, {"uuid": "4914726d-3902-3b70-823c-e739fe9b7948", "title": "Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/compass-therapeutics-stock-skyrockets-108-162000718.html", "providerPublishTime": 1738340400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W5ve9LofNukkX0a38W9plQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "fc2b055c-6da9-3c13-9fb7-491bc3c9cf47", "title": "CMRX Stock Skyrockets in 3 Months: Here's What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cmrx-stock-skyrockets-3-months-154300643.html", "providerPublishTime": 1738338180, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wYQLwM.yHAc_hHptSu_lhQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eA5p1GotBcGPlbcSkQjmLA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "1993fc3d-9486-3241-9256-66b753254aee", "title": "Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/alnylam-webcast-conference-call-discussing-130000457.html", "providerPublishTime": 1738242000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dI.jPoW.RoUsX2r5ZL_GbA--~B/aD00NDA7dz0xNTUyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4636983456b49fb83a6b3c3939c3311f", "width": 1552, "height": 440, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/GFb8bPB9YxpJrkSaVxKn3A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4636983456b49fb83a6b3c3939c3311f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALNY"]}, {"uuid": "2b0e7474-e673-3ec6-90a2-9b5e9074dec5", "title": "Should Invesco NASDAQ Next Gen 100 ETF (QQQJ) Be on Your Investing Radar?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/invesco-nasdaq-next-gen-100-155438458.html", "providerPublishTime": 1738252478, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XxozWWpdDFgGg6m0CzltLg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 900, "height": 602, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HGBb_w3iAqceoCyVMucmoA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "2f922e3b-cbd0-3d74-a063-0f442c68a90f", "title": "Alnylam Pharmaceuticals Insider Sold Shares Worth $14,988,720, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/alnylam-pharmaceuticals-insider-sold-shares-211517962.html", "providerPublishTime": 1738185317, "type": "STORY", "relatedTickers": ["ALNY"]}, {"uuid": "5421c822-d659-3f03-9de8-655f316a6554", "title": "New Strong Buy Stocks for January 27th", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-buy-stocks-january-27th-105600335.html", "providerPublishTime": 1737975360, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1hcqAcr._xcksqqDo_WNwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HBT", "ALNY", "GNTY", "APH"]}, {"uuid": "f74ee47e-7f11-3e6e-b09a-0bbf10593535", "title": "FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/fda-expands-label-azns-enhertu-161100900.html", "providerPublishTime": 1738080660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8ePNUSx6ARln9LO4PZCjpQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AZN", "4568.T", "CSTL", "BMRN", "ALNY"]}, {"uuid": "8c1ed65d-7039-35d8-9a64-70e9c654cb61", "title": "Top Analyst Reports for ServiceNow, Alibaba & Union Pacific", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/top-analyst-reports-servicenow-alibaba-185100170.html", "providerPublishTime": 1738003860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xAq6tiNpBYBfjYu3ujUYaw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/edfb3f3fb822d257e5cb9ad8a3cc2857", "width": 900, "height": 675, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vgCgoNiUGJgtcjamdHQe0A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/edfb3f3fb822d257e5cb9ad8a3cc2857", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["UNP", "NOW", "BABA", "FANG", "ELV", "TRV"]}]